1. Home
  2. BYSI vs FEAM Comparison

BYSI vs FEAM Comparison

Compare BYSI & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYSI
  • FEAM
  • Stock Information
  • Founded
  • BYSI 2010
  • FEAM 2016
  • Country
  • BYSI United States
  • FEAM United States
  • Employees
  • BYSI N/A
  • FEAM N/A
  • Industry
  • BYSI Biotechnology: Pharmaceutical Preparations
  • FEAM Major Chemicals
  • Sector
  • BYSI Health Care
  • FEAM Industrials
  • Exchange
  • BYSI Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • BYSI 71.0M
  • FEAM 70.5M
  • IPO Year
  • BYSI 2017
  • FEAM N/A
  • Fundamental
  • Price
  • BYSI $2.27
  • FEAM $3.69
  • Analyst Decision
  • BYSI
  • FEAM Strong Buy
  • Analyst Count
  • BYSI 0
  • FEAM 2
  • Target Price
  • BYSI N/A
  • FEAM $121.00
  • AVG Volume (30 Days)
  • BYSI 154.5K
  • FEAM 14.4K
  • Earning Date
  • BYSI 08-11-2025
  • FEAM 09-03-2025
  • Dividend Yield
  • BYSI N/A
  • FEAM N/A
  • EPS Growth
  • BYSI N/A
  • FEAM N/A
  • EPS
  • BYSI N/A
  • FEAM N/A
  • Revenue
  • BYSI N/A
  • FEAM N/A
  • Revenue This Year
  • BYSI N/A
  • FEAM N/A
  • Revenue Next Year
  • BYSI N/A
  • FEAM N/A
  • P/E Ratio
  • BYSI N/A
  • FEAM N/A
  • Revenue Growth
  • BYSI N/A
  • FEAM N/A
  • 52 Week Low
  • BYSI $0.98
  • FEAM $2.82
  • 52 Week High
  • BYSI $3.44
  • FEAM $29.44
  • Technical
  • Relative Strength Index (RSI)
  • BYSI 47.79
  • FEAM 44.18
  • Support Level
  • BYSI $2.33
  • FEAM $3.41
  • Resistance Level
  • BYSI $2.50
  • FEAM $3.82
  • Average True Range (ATR)
  • BYSI 0.32
  • FEAM 0.26
  • MACD
  • BYSI -0.09
  • FEAM 0.01
  • Stochastic Oscillator
  • BYSI 5.36
  • FEAM 52.31

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

Share on Social Networks: